ASPIRUS IRONWOOD HOSPITAL — History
CCN 231333 | 3-year financial timeline | COVID resilience: 49/100
🛡️ Public data only — no PHI permitted on this instance.
$65M
Latest Revenue (FY2022)
+3.2%
Revenue CAGR (3yr)
-3.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $61M | $67M | $65M | -2.7% | +3.2% |
| Operating Expenses | $62M | $66M | $68M | +3.1% | +4.9% |
| Operating Margin | -0.3% | 2.3% | -3.5% | -253.6% | +0.0% |
| Net Income | $-0M | $2M | $-2M | -249.4% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 3,330 | 3,930 | 3,655 | -7.0% | +4.8% |
| Medicare Day % | 40% | 37% | 43% | +17.0% | +3.2% |
| Medicaid Day % | 4% | 3% | 4% | +25.2% | -2.6% |
COVID Impact & Recovery
Resilience Score: 49/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +6.6% ($61M → $65M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+3.2%
This Hospital
+7.6%
State Avg
Latest Margin
-3.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $67M | -5.1% |
| FY2024 (proj) | $69M | -6.7% |
| FY2025 (proj) | $72M | -8.4% |